Delivery Order SPE2DR25D3009-SPE2DR26FWGF2
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $14,394.77 for 500 tablets of Cetirizine HCL 10 mg on September 25, 2025, with completion scheduled for September 26, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order valued at $1,194.41 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 10 mg tablets (300 count) on November 10, 2025, with completion scheduled for November 12, 2025. This competitively awarded, firm fixed-price delivery order includes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's critical role...
- The Defense Logistics Agency awarded a delivery order valued at $1,073.98 to AmerisourceBergen Drug Corp for the supply of Cetirizine HCL 10 mg tablets in quantities of 300 units. The contract was competitively awarded without set-aside designation and is classified as a firm fixed-price delivery order with an ultimate completion date of November 21, 2025. This award was issued on November 20, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $1,268.45 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Cetirizine HCL 5 mg tablets (100 count). The contract is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Cetirizine HCl 10 mg tablets (300-count) with a ceiling value of $1,632.98. This firm fixed-price delivery order is set to be completed by October 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award is issued under a non-set-aside, competitively awarded procurement process and represents a child contract action...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Cetirizine HCL 5 mg tablets (100-count packages) with a ceiling value of $7,861.18. This firm fixed price delivery order, with an ultimate completion date of September 17, 2025, represents a routine pharmaceutical procurement supporting federal medical supply needs. The contract was awarded on a competitive basis with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Cetirizine HCL 10 mg tablets in quantities of 500 units. This firm fixed-price delivery order, valued at $2,119.84, represents a non-competitive set-aside award and carries a completion deadline of August 22, 2025. The pharmaceutical products will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on August 14, 2025, for Cetirizine HCL 10 mg tablets (100-count) with a ceiling value of $1,088.45. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 15, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,354.67 to AmerisourceBergen Drug Corp for Cetirizine HCL 10 mg tablets (500-count supply) on July 14, 2025, with an ultimate completion date of July 15, 2025. This contract was awarded on a non-competitive, firm fixed-price basis under a delivery order structure and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a competitively awarded delivery order, this award represents a routine fulfillment...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Cetirizine HCL 10 mg tablets (300 count) with a ceiling value of $1,500.09. This firm fixed-price delivery order, with an ultimate completion date of November 13, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its...
- SPE2DR25D3009Indefinite Delivery Contract
- SPE2DR25D3009-SPE2DR26FWGF2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Cetirizine HCL 10 mg tablets (500 count) valued at $1,461.49 under a firm fixed-price contract. The award was made on December 2, 2025, with an ultimate completion date of December 3, 2025. This delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical supply, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The prime contract encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/1/25 |